As Earth's climate warms and changes, sustainable agricultural practices are critical for feeding a rapidly growing population. Can we genetically engineer crops to adapt to drought and other effects ...
The Chosun Ilbo on MSN
Genetic Testing Advances Toward 'Super Baby' Selection
Predictive indicators for whether a child will be vulnerable to certain diseases after birth, as well as their future height, ...
This monumental scientific achievement occurred within a context of intense international collaboration, rapid technical ...
The standard of care in cancer, adopted in the 1990s, is built on consensus based clinical research over large patient populations. However, if we know biologically each person is unique, then a ...
James “Jim” D. Watson, who helped discover the structure of DNA at age 25 and went on to spend 21 years as a Harvard biology ...
Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...
(Nasdaq: MGX) (the "Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create ...
New MGX-001 preclinical data supports advancement into clinical development; Demonstrated curative FVIII activity in non-human primates ...
According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...
Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.
Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback